In Vivo and Cytotoxicity Evaluation of Repaglinide-Loaded Binary Solid Lipid Nanoparticles After Oral Administration to Rats
- 1 June 2011
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 100 (6), 2406-2417
- https://doi.org/10.1002/jps.22454
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Formulation of an intravenous emulsion loaded with a clarithromycin–phospholipid complex and its pharmacokinetics in ratsInternational Journal of Pharmaceutics, 2009
- Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studiesJournal of Pharmaceutical and Biomedical Analysis, 2007
- Pharmacodynamic–pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat modelsBiomaterials, 2003
- Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycinJournal of Pharmaceutical Sciences, 2003
- An examination of the factors affecting intestinal lymphatic transport of dietary lipidsAdvanced Drug Delivery Reviews, 2001
- Insulin secretion, obesity, and potential behavioral influences: results from the Insulin Resistance Atherosclerosis Study (IRAS)Diabetes/Metabolism Research and Reviews, 2001
- Encapsulation of retinoids in solid lipid nanoparticles (SLN)Journal of Microencapsulation, 2001
- Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEuropean Journal of Pharmaceutics and Biopharmaceutics, 2000
- Formulation and Evaluation of Vinylpyrrolidone/Vinylacetate Copolymer Microspheres with CarbamazepinePharmaceutical Development and Technology, 2000
- Solid lipid nanoparticles (SLN) for controlled drug delivery – Drug release and release mechanismEuropean Journal of Pharmaceutics and Biopharmaceutics, 1998